HomeME • NASDAQ
add
23andMe Holding Co.
Previous close
$0.42
Day range
$0.39 - $0.42
Year range
$0.35 - $2.04
Market cap
198.09M USD
Avg Volume
4.48M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 64.03M | -30.69% |
Operating expense | 85.95M | -28.00% |
Net income | -208.83M | -225.80% |
Net profit margin | -326.16 | -370.04% |
Earnings per share | -0.43 | -206.96% |
EBITDA | -54.86M | 24.06% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 216.49M | -44.04% |
Total assets | 395.17M | -58.08% |
Total liabilities | 206.65M | -9.63% |
Total equity | 188.52M | — |
Shares outstanding | 490.26M | — |
Price to book | 1.10 | — |
Return on assets | -29.36% | — |
Return on capital | -40.86% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -208.83M | -225.80% |
Cash from operations | -25.78M | 42.65% |
Cash from investing | -2.15M | 34.73% |
Cash from financing | 2.00M | -23.25% |
Net change in cash | -25.93M | 43.57% |
Free cash flow | -2.42M | 92.90% |
About
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Founded
Apr 2006
Headquarters
Website
Employees
571